Ask AI
ProCE Banner Activity

Diagnosis, Prognosis, and Emerging Therapies in ET and PV  

Slideset

Download slides from a live webinar to gain expert perspectives on contemporary diagnosis and prognosis in ET and PV, as well as a look at emerging therapies in this space.

 

Released: December 17, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Target Audience

This activity is intended for hematologists and other healthcare professionals caring for patients with essential thrombocythemia and polycythemia vera.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify underlying MPNs such as ET and PV in patients presenting with thrombotic events that are otherwise unexplained

  • Diagnose patients with ET and PV, including bone marrow biopsies and assessment of risk of thrombotic events

  • Determine prognoses for individual patients with ET and PV using prognostic scoring system and identification of immune biomarkers

  • Engage patients with ET and PV in shared-decision making to better align treatment with both best practices and patient preferences on risks and benefits

  • Prepare clinical practice to incorporate new second-line agents for ET and PV upon approval